CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
Journal of Clinical Investigation · 15.07.2024 · 134 (14)
DOI: 10.1172/jci173096 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 04.06.2024. Verfasst von Gianluca Storci und 38 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Extracellular Vesicles, Immunotherapy, Adoptive, Antigens, CD19, Lymphoma, B-Cell. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEXTGENERATION EU, Italian Health ministry, Italian Ministry of University and reaserch.
Abstract (Originalsprache)
BACKGROUND Predicting immune effector cell–associated neurotoxicity syndrome (ICANS) in patients infused with CAR T cells is still a conundrum. This complication, thought to be consequent to CAR T cell activation, arises a few days after infusion, when circulating CAR T cells are scarce and specific CAR T cell–derived biomarkers are lacking. METHODS CAR + extracellular vesicle (CAR + EV) release was assessed in human CD19.CAR T cells cocultured with CD19 + target cells. A prospective cohort of 100 patients with B cell lymphoma infused with approved CD19.CAR T cell products was assessed for plasma CAR + EVs as biomarkers of in vivo CD19.CAR T cell activation. Human induced pluripotent stem cell–derived (iPSC-derived) neural cells were used as a model for CAR + EV-induced neurotoxicity. RESULTS In vitro release of CAR + EVs occurs within 1 hour after target engagement. Plasma CAR + EVs are detectable 1 hour after infusion. A concentration greater than 132.8 CAR + EVs/μL at hour +1 or greater than 224.5 CAR + EVs/μL at day +1 predicted ICANS in advance of 4 days, with a sensitivity and a specificity outperforming other ICANS predictors. ENO2 + nanoparticles were released by iPSC-derived neural cells upon CAR + EV exposure and were increased in plasma of patients with ICANS. CONCLUSION Plasma CAR + EVs are an immediate signal of CD19.CAR T cell activation, are suitable predictors of neurotoxicity, and may be involved in ICANS pathogenesis. TRIAL REGISTRATION NCT04892433, NCT05807789. FUNDING Life Science Hub–Advanced Therapies (financed by Health Ministry as part of the National Plan for Complementary Investments to the National Recovery and Resilience Plan [NRRP]: E.3 Innovative health ecosystem for APC fees and immunomonitoring).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
- IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
- Institute of Molecular Genetics, National Research Council of Italy, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences, Bellaria Hospital, Università di Bologna, Bologna, Italy.
- IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.
Förderung
- NEXTGENERATION EU
- Italian Health ministry
- Italian Ministry of University and reaserch
Zitieren
APA
Storci, G., De Felice, F., Ricci, F., Santi, S., Messelodi, D., Bertuccio, S. N., Laprovitera, N., Dicataldo, M., Rossini, L., De Matteis, S., Casadei, B., Vaglio, F., Ursi, M., Barbato, F., Roberto, M., Guarino, M., Asioli, G. M., Arpinati, M., Cortelli, P., …, & Bonifazi, F. (2024). CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells. Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/jci173096
Vancouver
Storci G, De Felice F, Ricci F, Santi S, Messelodi D, Bertuccio SN, et al. CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells. Journal of Clinical Investigation. 2024;134(14). doi:10.1172/jci173096
BibTeX
@article{Storci2024,
author = {Storci, Gianluca and De Felice, Francesco and Ricci, Francesca and Santi, Spartaco and Messelodi, Daria and Bertuccio, Salvatore Nicola and Laprovitera, Noemi and Dicataldo, Michele and Rossini, Lucrezia and De Matteis, Serena and Casadei, Beatrice and Vaglio, Francesca and Ursi, Margherita and Barbato, Francesco and Roberto, Marcello and Guarino, Maria and Asioli, Gian Maria and Arpinati, Mario and Cortelli, Pietro and Maffini, Enrico and Tomassini, Enrica and Tassoni, Marta and Cavallo, Carola and Iannotta, Francesco and Naddeo, Maria and Tazzari, Pier Luigi and Dan, Elisa and Pellegrini, Cinzia and Guadagnuolo, Serafina and Carella, Matteo and Sinigaglia, Barbara and Pirazzini, Chiara and Severi, Caterina and Garagnani, Paolo and Kwiatkowska, Katarzyna Malgorzata and Ferracin, Manuela and Zinzani, Pier Luigi and Bonafè, Massimiliano and Bonifazi, Francesca},
title = {CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {14},
doi = {10.1172/jci173096}
}
EUVIMED